Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06388109 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Positive Peers Intervention Clinical Trial

Study acronym: PoPIT
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Study sites: 6 to 7
    • Eligibility criteria expanded, about 5 words
    v7
  2. Site contacts updated at 1 of 6 sitesv6
  3. Site details revised at 6 of 6 sitesv5
  4. Eligibility criteria expanded, about 9 words
    • Site details revised at 6 of 6 sites
    v4
  5. Site details revised at 1 of 6 sitesv3
  6. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of May 2024 to Jun 3, 2024
    • Site details revised at 6 of 6 sites
    v2
  7. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this clinical trial is to learn if the Positive Peers mobile app intervention increases rates of viral suppression in young (13-34 y/o) persons with HIV. Does use of the Positive Peers app improve viral suppression among young minority persons with HIV? What user characteristics are associated with a) viral suppression, b) retention in care, and c) perceived HIV-related stigma? Participants will: * download the mobile app onto their personal smartphone * Use the mobile app as they find useful * complete online surveys at enrollment, 3 mo, 6, mo, 9 mo and 12 months.
Trial Details
NCT Number NCT06388109
Lead Sponsor MetroHealth Medical Center
Collaborators: Kent State University
Conditions
(from sponsor)		 HIV Infections
Related terms HIV Infections
Enrollment 250 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov